Skip to content

Clinical trials

Phase 2 Parkinson Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Country / region: Italy Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20092
20103
20112
20122
20132
20141
20151
20163
20173
20181
20202
20212
20223
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated6
Active, not recruiting3
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Biogen2
IRCCS San Raffaele Roma2
NeuroDerm Ltd.2
UCB Biopharma SRL2
Abbott Products1
Acorda Therapeutics1
Azienda Ospedaliera Cardinale G. Panico1
Bial R&D Investments, S.A.1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease33
Dyskinesias6
Movement Disorders5
Parkinsonian Disorders4
Neurodegenerative Diseases2
Basal Ganglia Diseases1
Central Nervous System Diseases1
Dyskinesia, Drug-Induced1
Psychotic Disorders1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.